Table 1.
Clinical characteristics of patients with hepatocellular carcinoma in this study.
| Characteristics | PTCD group(n = 12) | ENBD group (n = 11) | p |
|---|---|---|---|
| Age (years) | 54.42(32–68) | 53.36(44–67) | 0.82 |
| Sex | 0.59 | ||
| Male | 10 | 9 | |
| Female | 1 | 2 | |
| Hepatitis B virus | 0.48 | ||
| Yes | 10 | 11 | |
| No | 2 | 0 | |
| Site of tube placement | 1 | ||
| Right primary duct | 9 | 9 | |
| Left primary duct | 3 | 2 | |
| Size of tumor (mm) | 31.92(13–46) | 33.18(20–50) | 0.92 |
| Distance of tumor to bile duct(mm) | 1.92(0–5) | 2.18(0–5) | 0.66 |
| Total time of MWA(min) | 9.09(6–15) | 7.04(3–15) | 0.69 |
| Total bilirubin (mg/dL) | 23.76(8.10–50.8) | 19.94(8.5–52.1) | 0.39 |
| Albumin (g/dL) | 38.88(29.1–47.00) | 43.81(35.00–64.70) | 0.27 |
| Alanine aminotransferase(U/L) | 58.08(18–221) | 33.91(7–66) | 1 |
| Prothrombin time(s) | 12.89(10.9–15.3) | 12.1(10.3–13.6) | 0.24 |
| Platelets(×109/L) | 112.92(54–206) | 139.91(41–183) | 0.22 |
| Child-Pugh class | 1 | ||
| A | 9 | 8 | |
| B | 3 | 3 | |
| BCLC stage | 0.68 | ||
| 0 | 9 | 7 | |
| A | 3 | 4 |
Values are expressed as number of patients or median (range).
PTCD, percutaneous transhepatic cholangial drainage; ENBD, endoscopic nasobiliary drainage; MWA, microwave ablation; BCLC, Barcelona Clinic Liver Cancer; NS, not significant.
Statistical analysis was performed using either the Mann-Whitney U test or Fisher's exact test.